Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taurus Pharma is a German pharmaceutical company specializing in the development and marketing of high-quality medicinal products, with a strong focus on dermatology and urology. The company is best known for its market-leading antifungal treatments, such as Ciclopoli, which utilizes a unique water-soluble lacquer technology for treating nail fungus. Since its acquisition by the Klosterfrau Group in 2014, Taurus Pharma has continued to expand its portfolio of prescription and over-the-counter (OTC) medications. Its business model emphasizes niche therapeutic areas where it can provide specialized solutions for patients and healthcare providers. The company maintains a significant presence in the European market, particularly in Germany, through its specialized sales force and established brand reputation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taurus Pharma.